Mifepristone 10 or 5 mg for 6 Months to Treat Uterine Fibroids
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The objectives of this study are to estimate the efficacy and safety of the daily
administration for 6 months of 5 mg versus 10 mg. A 6 month follow-up of subjects is carried
out to estimate how the effects of mifepristone are kept in time.
The hypothesis of this study is that both mifepristone doses reduce the volume of the myoma
up to 50% in six months treatment.